Know How to Manage Dyslipidemia in Patients Living With HIV

August 2019

Better antiretroviral therapy means more patients with HIV will face dyslipidemia and CV disease...instead of opportunistic infections.

HIV itself increases CV risk...possibly by triggering inflammatory mediators linked to atherosclerosis or platelet activation.

And early use of antiretrovirals is key...since uncontrolled HIV carries a higher risk of MI, stroke, heart failure, etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote